Evidence map›Paper›PMID 25632930›Full record

ReviewSeminars in liver disease2015

Overview of microRNA biology.

Ashley M Mohr, Justin L Mott

Open access · hybridAbstract readReview
In one paragraph

Review in Seminars in liver disease, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 609 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
609citing papers in PubMed, 5 pooled it
9.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

609 citing papers in PubMed, 5 syntheses or guidelines pooled it, 1,071 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Review
  7. Review
  8. MiR-940 Suppresses Ferroptosis by Controlling Expression of Key Regulatory Genes.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. MiR-21 modulatesNon-coding RNA research · 2026
    Article
  20. Article

549 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Ashley M MohrDepartment of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, Nebraska.
Justin L MottDepartment of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, Nebraska.
University of Nebraska Medical Center · US

Funding

Apoptosis Effectors Targeted By Hedgehog-Supported MicroRNAsR03DK092263 · NIDDK · UNIVERSITY OF NEBRASKA MEDICAL CENTER · PI MOTT, JUSTIN L. · 2011 to 2012
$149k
NIDDK NIH HHS R03 DK092263
6 · The paper itself

Abstract

In considering an overview of microRNA biology, it is useful to consider microRNAs as a part of cellular communication. At the simplest level, microRNAs act to decrease the expression of messenger RNAs that contain stretches of sequence complementary to the microRNA. This function can be likened to the function of endogenous or synthetic short interfering RNA. However, microRNA function is more complicated and nuanced than this "on-off" model would suggest. Further, many microRNA targets are themselves noncoding RNAs. In this review, the authors discuss the role of microRNAs in shaping the proteome of the cell in a way that is consistent with microRNA involvement in a highly regulated conversation, sensitive to outside influence and internal feedback.

Indexed as

Alternative SplicingGene Expression RegulationGenetic MarkersRibonucleoproteinsRNA Processing, Post-TranscriptionalHumansMicroRNAsPolymorphism, Single NucleotideGenetic MarkersMicroRNAsRibonucleoproteins

Identifiers

PMID25632930
PMCPMC4797991
OpenAlexW2059117644

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.